INMODE LTD (INMD) Stock Fundamental Analysis

NASDAQ:INMD • IL0011595993

15.22 USD
+0.13 (+0.83%)
At close: Feb 20, 2026
15.21 USD
-0.01 (-0.07%)
After Hours: 2/20/2026, 8:00:01 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

7

INMD gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 185 industry peers in the Health Care Equipment & Supplies industry. Both the health and profitability get an excellent rating, making INMD a very profitable company, without any liquidiy or solvency issues. INMD is valued quite cheap, but it does not seem to be growing. This makes INMD very considerable for value investing!


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

  • In the past year INMD was profitable.
  • In the past year INMD had a positive cash flow from operations.
  • In the past 5 years INMD has always been profitable.
  • Each year in the past 5 years INMD had a positive operating cash flow.
INMD Yearly Net Income VS EBIT VS OCF VS FCFINMD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 12.24%, INMD belongs to the top of the industry, outperforming 95.14% of the companies in the same industry.
  • INMD has a Return On Equity of 13.73%. This is amongst the best in the industry. INMD outperforms 89.73% of its industry peers.
  • INMD has a Return On Invested Capital of 10.44%. This is amongst the best in the industry. INMD outperforms 89.73% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for INMD is significantly above the industry average of 8.75%.
  • The last Return On Invested Capital (10.44%) for INMD is well below the 3 year average (14.88%), which needs to be investigated, but indicates that INMD had better years and this may not be a problem.
Industry RankSector Rank
ROA 12.24%
ROE 13.73%
ROIC 10.44%
ROA(3y)19.41%
ROA(5y)23.56%
ROE(3y)21.54%
ROE(5y)26.69%
ROIC(3y)14.88%
ROIC(5y)21.59%
INMD Yearly ROA, ROE, ROICINMD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40 50

1.3 Margins

  • With an excellent Profit Margin value of 25.33%, INMD belongs to the best of the industry, outperforming 96.22% of the companies in the same industry.
  • In the last couple of years the Profit Margin of INMD has declined.
  • The Operating Margin of INMD (23.05%) is better than 94.59% of its industry peers.
  • In the last couple of years the Operating Margin of INMD has declined.
  • The Gross Margin of INMD (78.54%) is better than 91.89% of its industry peers.
  • INMD's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 23.05%
PM (TTM) 25.33%
GM 78.54%
OM growth 3Y-19.12%
OM growth 5Y-8.19%
PM growth 3Y-10.69%
PM growth 5Y-6.99%
GM growth 3Y-2.15%
GM growth 5Y-1.58%
INMD Yearly Profit, Operating, Gross MarginsINMD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

10

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), INMD is creating some value.
  • The number of shares outstanding for INMD has been reduced compared to 1 year ago.
  • Compared to 5 years ago, INMD has less shares outstanding
  • There is no outstanding debt for INMD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
INMD Yearly Shares OutstandingINMD Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
INMD Yearly Total Debt VS Total AssetsINMD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

2.2 Solvency

  • An Altman-Z score of 10.54 indicates that INMD is not in any danger for bankruptcy at the moment.
  • INMD has a Altman-Z score of 10.54. This is amongst the best in the industry. INMD outperforms 89.19% of its industry peers.
  • INMD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 10.54
ROIC/WACC1.22
WACC8.58%
INMD Yearly LT Debt VS Equity VS FCFINMD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

2.3 Liquidity

  • A Current Ratio of 9.88 indicates that INMD has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 9.88, INMD belongs to the top of the industry, outperforming 91.89% of the companies in the same industry.
  • INMD has a Quick Ratio of 8.83. This indicates that INMD is financially healthy and has no problem in meeting its short term obligations.
  • INMD has a Quick ratio of 8.83. This is amongst the best in the industry. INMD outperforms 91.35% of its industry peers.
Industry RankSector Rank
Current Ratio 9.88
Quick Ratio 8.83
INMD Yearly Current Assets VS Current LiabilitesINMD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. Growth

3.1 Past

  • INMD shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -8.99%.
  • Measured over the past years, INMD shows a quite strong growth in Earnings Per Share. The EPS has been growing by 8.96% on average per year.
  • INMD shows a decrease in Revenue. In the last year, the revenue decreased by -6.16%.
  • The Revenue has been growing by 12.45% on average over the past years. This is quite good.
EPS 1Y (TTM)-8.99%
EPS 3Y-12.64%
EPS 5Y8.96%
EPS Q2Q%9.52%
Revenue 1Y (TTM)-6.16%
Revenue growth 3Y-6.57%
Revenue growth 5Y12.45%
Sales Q2Q%6.13%

3.2 Future

  • Based on estimates for the next years, INMD will show a small growth in Earnings Per Share. The EPS will grow by 5.61% on average per year.
  • The Revenue is expected to grow by 1.82% on average over the next years.
EPS Next Y3.73%
EPS Next 2Y5.61%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year1.75%
Revenue Next 2Y3.26%
Revenue Next 3Y1.82%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
INMD Yearly Revenue VS EstimatesINMD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M 400M 500M
INMD Yearly EPS VS EstimatesINMD Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5 2 2.5

More info and screens

Find the best growth stocksShow best growing peers

8

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 9.40 indicates a reasonable valuation of INMD.
  • Based on the Price/Earnings ratio, INMD is valued cheaply inside the industry as 96.22% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Earnings ratio of 26.99, INMD is valued rather cheaply.
  • The Price/Forward Earnings ratio is 9.06, which indicates a very decent valuation of INMD.
  • 96.22% of the companies in the same industry are more expensive than INMD, based on the Price/Forward Earnings ratio.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 28.02, INMD is valued rather cheaply.
Industry RankSector Rank
PE 9.4
Fwd PE 9.06
INMD Price Earnings VS Forward Price EarningsINMD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of INMD indicates a rather cheap valuation: INMD is cheaper than 99.46% of the companies listed in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of INMD indicates a rather cheap valuation: INMD is cheaper than 97.30% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 11.41
EV/EBITDA 3.75
INMD Per share dataINMD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • INMD has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)2.52
PEG (5Y)1.05
EPS Next 2Y5.61%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for INMD!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

INMODE LTD

NASDAQ:INMD (2/20/2026, 8:00:01 PM)

After market: 15.21 -0.01 (-0.07%)

15.22

+0.13 (+0.83%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-10
Earnings (Next)04-27
Inst Owners59.58%
Inst Owner Change-3.46%
Ins Owners10.65%
Ins Owner ChangeN/A
Market Cap962.06M
Revenue(TTM)370.50M
Net Income(TTM)93.83M
Analysts74.29
Price Target16.93 (11.24%)
Short Float %5.85%
Short Ratio3.49
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.57%
Min EPS beat(2)5.11%
Max EPS beat(2)8.04%
EPS beat(4)3
Avg EPS beat(4)2.52%
Min EPS beat(4)-13.69%
Max EPS beat(4)10.61%
EPS beat(8)4
Avg EPS beat(8)-4.69%
EPS beat(12)7
Avg EPS beat(12)-1.79%
EPS beat(16)11
Avg EPS beat(16)1.34%
Revenue beat(2)1
Avg Revenue beat(2)0.45%
Min Revenue beat(2)-2.48%
Max Revenue beat(2)3.38%
Revenue beat(4)1
Avg Revenue beat(4)-1.08%
Min Revenue beat(4)-2.87%
Max Revenue beat(4)3.38%
Revenue beat(8)2
Avg Revenue beat(8)-5.72%
Revenue beat(12)4
Avg Revenue beat(12)-4.28%
Revenue beat(16)8
Avg Revenue beat(16)-2.02%
PT rev (1m)0%
PT rev (3m)-1.19%
EPS NQ rev (1m)-11.49%
EPS NQ rev (3m)-12.36%
EPS NY rev (1m)0%
EPS NY rev (3m)-2.47%
Revenue NQ rev (1m)-1.98%
Revenue NQ rev (3m)-2.63%
Revenue NY rev (1m)-1.53%
Revenue NY rev (3m)-3.37%
Valuation
Industry RankSector Rank
PE 9.4
Fwd PE 9.06
P/S 2.6
P/FCF 11.41
P/OCF 11.28
P/B 1.41
P/tB 1.41
EV/EBITDA 3.75
EPS(TTM)1.62
EY10.64%
EPS(NY)1.68
Fwd EY11.04%
FCF(TTM)1.33
FCFY8.76%
OCF(TTM)1.35
OCFY8.86%
SpS5.86
BVpS10.81
TBVpS10.81
PEG (NY)2.52
PEG (5Y)1.05
Graham Number19.85
Profitability
Industry RankSector Rank
ROA 12.24%
ROE 13.73%
ROCE 12.27%
ROIC 10.44%
ROICexc 51.74%
ROICexgc 51.74%
OM 23.05%
PM (TTM) 25.33%
GM 78.54%
FCFM 22.75%
ROA(3y)19.41%
ROA(5y)23.56%
ROE(3y)21.54%
ROE(5y)26.69%
ROIC(3y)14.88%
ROIC(5y)21.59%
ROICexc(3y)140.37%
ROICexc(5y)572.43%
ROICexgc(3y)140.37%
ROICexgc(5y)572.43%
ROCE(3y)17.49%
ROCE(5y)25.39%
ROICexgc growth 3Y-64.14%
ROICexgc growth 5Y-69.81%
ROICexc growth 3Y-64.14%
ROICexc growth 5Y-69.81%
OM growth 3Y-19.12%
OM growth 5Y-8.19%
PM growth 3Y-10.69%
PM growth 5Y-6.99%
GM growth 3Y-2.15%
GM growth 5Y-1.58%
F-Score4
Asset Turnover0.48
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 139.86%
Cap/Sales 0.26%
Interest Coverage 250
Cash Conversion 99.04%
Profit Quality 89.83%
Current Ratio 9.88
Quick Ratio 8.83
Altman-Z 10.54
F-Score4
WACC8.58%
ROIC/WACC1.22
Cap/Depr(3y)114.97%
Cap/Depr(5y)150.7%
Cap/Sales(3y)0.19%
Cap/Sales(5y)0.24%
Profit Quality(3y)83.88%
Profit Quality(5y)93.71%
High Growth Momentum
Growth
EPS 1Y (TTM)-8.99%
EPS 3Y-12.64%
EPS 5Y8.96%
EPS Q2Q%9.52%
EPS Next Y3.73%
EPS Next 2Y5.61%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-6.16%
Revenue growth 3Y-6.57%
Revenue growth 5Y12.45%
Sales Q2Q%6.13%
Revenue Next Year1.75%
Revenue Next 2Y3.26%
Revenue Next 3Y1.82%
Revenue Next 5YN/A
EBIT growth 1Y-23.82%
EBIT growth 3Y-24.44%
EBIT growth 5Y3.24%
EBIT Next Year4.81%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-36.15%
FCF growth 3Y-22.35%
FCF growth 5Y1.38%
OCF growth 1Y-35.73%
OCF growth 3Y-22.28%
OCF growth 5Y1.48%

INMODE LTD / INMD FAQ

Can you provide the ChartMill fundamental rating for INMODE LTD?

ChartMill assigns a fundamental rating of 7 / 10 to INMD.


Can you provide the valuation status for INMODE LTD?

ChartMill assigns a valuation rating of 8 / 10 to INMODE LTD (INMD). This can be considered as Undervalued.


How profitable is INMODE LTD (INMD) stock?

INMODE LTD (INMD) has a profitability rating of 8 / 10.


Can you provide the PE and PB ratios for INMD stock?

The Price/Earnings (PE) ratio for INMODE LTD (INMD) is 9.4 and the Price/Book (PB) ratio is 1.41.